Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old.
- You are willing and able to give your consent to take part in the study.
- You are able to read and understand written and spoken instructions in Dutch.
- You are willing and able to understand what the study involves and what it is about.
Who may not be able to join:
- Your Body Mass Index (BMI, a measure of body weight relative to height) is 35 or above.
- You have another illness that could broadly affect your muscles or affect how they appear in medical scans in ways unrelated to what the study is looking at (confirm with trial site).
- You are dependent on a wheelchair to get around.
- You are pregnant.
- You have a fear of enclosed spaces (claustrophobia), which could make having an MRI scan difficult.
- You have a pacemaker or a defibrillator (devices that help regulate your heart).
- You have a nerve stimulator device implanted in your body.
- You have surgical clips in your brain.
- You have any metal fragments in or around your eyes.
- You have a cochlear implant (a device implanted to help with hearing) or other magnetic metal implants in your body, for example implants used to treat scoliosis (a curved spine).
- You are unable to lie flat on your back for 60 minutes.
- You require a breathing machine during the day, either continuously or at certain times.
- You have previously had surgery for scoliosis (spinal curvature).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nens Van Alfen, MD. PhD., Radboud University Medical Center
Phone: 0243611111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Stage I: Repeatability and feasibility of the ultrasound-defined muscle contractile performance.; Stage II: Difference in contractile performance, MRI measures and clinical measures between healthy individuals and patients with FSHD.; Stage II: Change of contractile performance, MRI measures and clinical measures with FSHD disease progression after 1 year.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.